Prevalence and outcome of partial remission in depression

Journal of Psychiatry and Neuroscience

Volumn 27, Issue 4, 2002, Pages 241-247

  Tranter, Richard ^a   O'Donovan, Claire ^a   Chandarana, Praful ^a   Kennedy, Sidney ^a  

^a Hergest Unit   (United Kingdom)

Author keywords

Antidepressive agents; Behavioral symptoms; Cognitive therapy; Depressive disorder; Drug therapy; Psychiatric status rating scales; Psychotherapy; Recurrence; Remission induction; Treatment outcome

Indexed keywords

AMITRIPTYLINE;

ANHEDONIA; ANXIETY; ARTICLE; CHRONICITY; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DISABILITY; FATIGUE; HUMAN; MEDICAL RESEARCH; MOOD; PREVALENCE; PSYCHOTHERAPY; REMISSION; RISK FACTOR; SLEEP DISORDER; SOCIAL CARE; STROKE; SUICIDE ATTEMPT; SYMPTOM;

ADULT; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; PREVALENCE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 0036655808     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Lifetime and 12-month prevalence of DSM III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
2. Depression, disability days and days lost from work in a prospective epidemiologic survey
3. Subthreshold depression and depressive disorder: Clinical characteristics of general medicine and mental health specialty outpatients
4. Residual symptoms after partial remission: An important outcome in depression
5. Relapse in major depressive disorder: Analysis with the life table and regression models
6. Treating depression to remission
7. The predictors of persistence of depression in primary care
8. Outcomes of patients with chronic affective disorder: A five-year follow-up
9. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence
10. Long-term prognosis of depression in primary care
11. Relapse after cognitive behavior therapy of depression: Potential implications for longer courses of treatment
12. Residual symptoms in depressed patients who respond acutely to fluoxetine
13. Effect of continuation treatment on residual symptoms in late-life depression: How well is "well"?
14. Factors associated with outcome in major depression: A 6-month prospective study
15. Subsyndromal symptomatic depression (SSD): A new mood disorder?
16. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depression
17. Low-intensity treatment of depression in primary care: Is it problematic
18. Personality in the prediction of long-term outcomes of depression
19. Outcome of depression and anxiety in primary care: A three-wave 3 1/2 year study of psychopathology and disability
20. Prognosis of depression in the elderly: A comparison with younger patients
21. Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse
22. Refractory depression: Prediction of non-response by clinical indicators
23. Cognitive-behavioral treatment of residual symptoms in primary major depressive disorder
24. Residual symptoms in major depression: A comparison with normal controls
25. Major depression and the five-factor model of personality
26. Does major depression result in lasting personality change?
27. A longitudinal twin study of personality and major depression in women
28. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine
29. Remission and relapse in major depression: A two-year prospective follow-up study
30. Depressive relapse and incomplete recovery from index episode
31. Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression
32. Biological markers, treatment outcome, and 1-year follow-up in endogenous depression: Electroencephalographic sleep studies and response to cognitive therapy
33. Six-year outcome for cognitive behavioral treatment of residual symptoms primary major depressive disorder
34. How effective and safe is continuation therapy in elderly depressed patients: Factors affecting relapse rate
35. Differential relapse following cognitive therapy and pharmacotherapy for depression
36. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?
37. Depression and 18-month prognosis and myocardial infarction
38. Gender, depression, and one-year prognosis after myocardial infarction
39. Depression and 1-year prognosis in unstable angina
40. Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. The Stockholm Female Coronary Risk Study
41. Symptoms of depression as a prospective risk factor for stroke
42. Amitriptyline v. the rest: Still the leading antidepressant after 40 years of randomised controlled trials
43. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability
44. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
45. Prevention of relapse in residual depression by cognitive therapy
46. Prevention of recurrent depression with cognitive behavioural therapy
47. Combined psychotherapy and pharmacotherapy for depression: A systematic analysis of the evidence
48. A comparison of nefazodone, the cognitive-behavioural analysis system of psychotherapy, and their combination for the treatment of chronic depression